MedTrace Logo

Preventing Recurrent Gestational Diabetes With Metformin

NCT02394158 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2019-08-13

No results posted yet for this study

Summary

Study Hypothesis: Intervention with metformin therapy early in pregnancy will prevent gestational diabetes mellitus recurring in previously affected pregnancies.

Conditions

  • Gestational Diabetes Mellitus

Interventions

DRUG

Metformin

DRUG

placebo

Sponsors & Collaborators

  • Imperial College Healthcare NHS Trust

    collaborator OTHER

  • London North West Healthcare NHS Trust

    collaborator OTHER

  • The Novo Nordisk UK Research Foundation

    collaborator UNKNOWN

  • Imperial College London

    lead OTHER

Principal Investigators

  • Stephen Robinson, FRCP, MD · Imperial College NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-27
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02394158 on ClinicalTrials.gov